Abstract
We derive and validate a novel and analytic method for estimating the probability that an epidemic has been eliminated (i.e. that no future local cases will emerge) in real time. When this probability crosses 0.95 an outbreak can be declared over with 95% confidence. Our method is easy to compute, only requires knowledge of the incidence curve and the serial interval distribution, and evaluates the statistical lifetime of the outbreak of interest. Using this approach, we rigorously show how the time-varying under-reporting of infected cases will artificially inflate the inferred probability of elimination, leading to premature (false-positive) end-of-epidemic declarations. Contrastingly, we prove that incorrectly identifying imported cases as local will deceptively decrease this probability, resulting in delayed (false-negative) declarations. Failing to sustain intensive surveillance during the later phases of an epidemic can therefore substantially mislead policymakers on when it is safe to remove travel bans or relax quarantine and social distancing advisories. World Health Organisation guidelines recommend fixed (though disease-specific) waiting times for end-of-epidemic declarations that cannot accommodate these variations. Consequently, there is an unequivocal need for more active and specialised metrics for reliably identifying the conclusion of an epidemic.
Author Summary Deciding on when to declare an infectious disease epidemic over is an important and non-trivial problem. Early declarations can mean that interventions such as lockdowns, social distancing advisories and travel bans are relaxed prematurely, elevating the risk of additional waves of the disease. Late declarations can unnecessarily delay the re-opening of key economic sectors, for example trade, tourism and agriculture, potentially resulting in significant financial and livelihood losses. Here we develop and test a novel and exact data-driven method for optimising the timing of end-of-epidemic declarations. Our approach converts observations of infected cases up to any given time into a prediction of the likelihood that the epidemic is over at that time. Using this method, we quantify the reliability of end-of-epidemic declarations in real time, under ideal case surveillance, showing that it can depend strongly on past infection numbers. We then prove that failing to compensate for practical issues such as the time-varying under-reporting and importing of cases necessarily results in premature and delayed declarations, respectively. These variations and biases cannot be accommodated by current worldwide declaration guidelines. Sustained and intensive surveillance coupled with more adaptive declaration metrics are vital if informed end-of-epidemic declarations are to be made.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
KVP and CAD acknowledge joint centre funding from the UK Medical Research Council and Department for International Development under grant reference MR/R015600/1. RNT thanks Christ Church (Oxford) for funding via a Junior Research Fellowship. CAD thanks the UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London in partnership with Public Health England (PHE) for funding (grant HPRU/2012/10080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data and code are freely available at https://github.com/kpzoo/End-of-epidemic-declarations
